Medtronic earns expanded FDA nod for deep brain stim
December 5, 2025
Medtronic (NYSE: MDT)+
announced that the FDA approved expanded labeling for its deep brain stimulation (DBS) offering.
Medtronic (NYSE: MDT)+
announced that the FDA approved expanded labeling for its deep brain stimulation (DBS) offering.
Cardiawave announced that it received CE mark approval for Valvosoft, its non-invasive therapeutic alternative for treating aortic stenosis (AS).
Insulet (Nasdaq: PODD)+
announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.
Atraverse Medical announced today that it received FDA clearance for its fully integrated Hotwire transseptal access system.
Boston Scientific (NYSE: BSX)+
announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) catheter.
Carlsmed (Nasdaq:CARL) announced today that it began the U.S. launch of its Aprevo technology platform for cervical fusion surgeries.
Medtronic (NYSE: MDT)+
announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.
Eko Health announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized national payment for its Sensora platform.
Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 Day CGM.
Medtronic (NYSE: MDT)+
today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G pump.